External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Ophthalmology AAO 2024
Roche and Genentech at

AAO 2024

October 18 - October 21
Chicago, USA / Virtual (Hybrid)
aao.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
01:00 PM
Duration 3mins Chicago, USA
ELEVATUM, the First Industry Sponsored Trial Focused on Underrepresented Patients in Retina in the US
Emanuelli A, Amador M, Ha R, Milunovich S, Yang M
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:57 PM
Duration 7mins Location: ARIE CROWN
Treatment Response and Safety ​of Faricimab▼ in Underrepresented Patients With DME: Year 1 Results From ELEVATUM in the US
Brown J, Amador M, Cunningham M, Coney J, Emanuelli A, Huddleston S, Scott A, Milunovich S, Yang M, Lu XY, Gonzalez L
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:50 PM
Duration 10mins Location: Lakeside Center (East Building) Room: E350
Results from the Phase 1 DOVETAIL Study of Anti-IL6 Monoclonal Antibody Vamikibart for Uveitic Macular Edema
Khurana R, Steeples L, Elze M, MacGregor L, Stoilov I, Silverman D, Mesquida M, Haskova Z
Ophthalmology | Uveitis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
02:45 PM
Duration 6mins S103A
Efficacy and Safety of Faricimab▼ in ALTIMETER: A Phase 2b Trial Exploring Biomarkers of Angiopoietin-2 Inhibition in Patients With Diabetic Macular Edema
Ziemssen F, Amador M, Dieckmann A, Gibson K, Glittenberg C, Kotak A, Mar F, Souverain A, Titz B, Vujosevic S, Fawzi A
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 6mins S103A
Impact of Early Intraretinal Fluid Reduction on Two-Year Outcomes in Diabetic Macular Edema
Lim J, Wang Y, Hibar D, Maunz A, Lu H, Albrecht T, Gibson K, Willis J, Chang D, Litts K
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 6mins S103A
Greater Reduction in Hard Exudates With Faricimab▼ vs Aflibercept in Patients With DME: Biomarker Results From the Phase 3 YOSEMITE/RHINE Trials
Dinah C, Vujosevic S, Goldberg R, Ip M, Rahimy E, Amador M, Gibson K, Glittenberg C, Maunz A, O'Leary O, Uschner D
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
04:15 PM
Duration 3mins Chicago, USA
Comparison of Diabetic Retinopathy Progression With 7 Field and Ultrawide Imaging in the Phase 3 YOSEMITE/RHINE Studies
Domalpally A, Tang Y, Wykoff C, Khanani A, Gibson K, Willis J, Haskova Z
Ophthalmology | Diabetic Retinopathy - Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 3mins Chicago, USA
Comparison of the Relative Effectiveness of Faricimab▼ vs Aflibercept 8 mg in Diabetic Macular Edema (DME) and Neovascular Age-Related Macular Degeneration (nAMD)​
Lim J, Keane P, Leng T, Siedlecki J, Holekamp N, Mar F, Gibson K, Paulo T, Buehrer C, Tabano D
Ophthalmology | Diabetic Macular Edema - Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.